| Coagulation problems in liver disease. | |
| | |
MedLine Citation:
|
PMID: 10850568 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Three topics are addressed in this manuscript: (1) the causes of abnormal hemostasis in cirrhosis; (2) the evaluation of hemostasis in cirrhotic patients before invasive procedures or in the presence of bleeding; and (3) the assessment of the effect of recombinant activated factor VII (rFVIIa; NovoSeven, Novo Nordisk A/S, Bagsvaerd, Denmark) on hemostatic function in cirrhotic patients. Laboratory experiments are described that could enhance the understanding of the effect of rFVIIa on blood coagulation during hemostasis in cirrhotic patients. |
| | |
Authors:
|
S I Rapaport |
Related Documents
:
|
1318978 - Clinical utility of pulsed doppler in the detection of arterioportal shunting in patien... 18242498 - Role of methotrexate in the treatment of chronic cholestatic disorders. 19453948 - What is behind the presence of anti-neutrophil cytoplasmatic antibodies in chronic live... 10628928 - Prediction of the development of hepato-cellular-carcinoma in patients with liver cirrh... 6429988 - Somatomedin a increments are diminished in acromegaly with concomitant hyperprolactinae... 19879968 - Long-term outcome of patients with obscure gastrointestinal bleeding investigated by do... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis Volume: 11 Suppl 1 ISSN: 0957-5235 ISO Abbreviation: Blood Coagul. Fibrinolysis Publication Date: 2000 Apr |
Date Detail:
|
Created Date: 2000-10-03 Completed Date: 2000-10-03 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 9102551 Medline TA: Blood Coagul Fibrinolysis Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: S69-74 Citation Subset: IM |
Affiliation:
|
University of California, San Diego, USA. srapaport@ucsd.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Blood Coagulation* Blood Coagulation Disorders / blood, drug therapy, etiology* Factor VIIa / therapeutic use Female Humans Liver Diseases / blood*, complications* Male Recombinant Proteins / therapeutic use Thrombin |
| Chemical | |
Reg. No./Substance:
|
0/Recombinant Proteins; EC 3.4.21.21/Factor VIIa; EC 3.4.21.5/Thrombin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Recombinant activated factor VII (NovoSeven) treatment of platelet-related bleeding disorders. Inter...
Next Document: Clinical aspects of bleeding complications in cirrhotic patients.